Efficacy of cyclosporin in the treatment of atopic dermatitis in dogs - Combined results from two veterinary dermatology referral centres

Australian Veterinary Journal

Volumn 82, Issue 11, 2004, Pages 681-685

  Burton, G ^a   Burrows, A ^b   Walker, R ^c   Robson, D ^a   Bassett, R ^a   Bryden, S ^b   Hill, A ^c  

^a Melbourne Veterinary Referral Centre   (Australia)

^b MURDOCH UNIVERSITY   (Australia)

^c Novartis Animal Health Australasia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS;

CYCLOSPORIN; DERMATOLOGICAL AGENT;

ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; AUSTRALIA; CLINICAL TRIAL; DOG; DOG DISEASE; FEMALE; HOSPITALIZATION; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATHOLOGY; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMALS; CYCLOSPORINE; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; DOG DISEASES; DOGS; FEMALE; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WESTERN AUSTRALIA;

EID: 23244449751     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2004.tb12153.x     Document Type: Article

References (17)

1. Olivry T, Naydan DK, Moore PF. Characterization of the cutaneous inflammatory infiltrate in canine atopic dermatitis. Am J Dermatopathol 1997;19:477-486.
2. Griffin CE, De Boer DJ. The ACVD Task Force on canine atopic dermatitis (XIV): Clinical manifestations of canine atopic dermatitis. Vet Immunol Immunopathol 2001;81:255.
3. Bond R, Ferguson EA, Curtis CF, Craig JM, Lloyd DH. Factors associated with elevated cutaneous Malassezia pachydermatitis populations in dogs with pruritic skin disease. J Small Anim Pract 1996;37:103-107.
4. DeBoer DJ, Hillier A. The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis. Vet Immunol Immunopathol 2001;81: 271-276.
5. Olivry T, Sousa CA. The ACVD task force on canine atopic dermatitis (XIX): general principles of therapy. Vet Immunol Immunopathol 2001;81:311-316.
6. Olivry T, Steffan J, Fisch RD et al. Randomized controlled trial of the efficacy of cyclosporine in the treatment of atopic dermatitis in dogs. J Am Vet Med Assoc 2002;221:370-377.
7. Steffan J, Alexander D, Brovedani F, Fisch RD. Comparison of cyclosporin A with methylprednisolone for treatment of canine atopic dermatitis- a parallel randomized controlled trial. Vet Dermatol 2003;14:1:11-22.
8. Camp RDR, Reitamo S, Friedmann PS, Ho V, Heule F. Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop. Br J Dermatol 1993;129:217-220.
9. Lim KK, Su WP, Schroeter AL et al. Cyclosporine in the treatment of dermatologic disease: an update. Mayo Clinic Proceedings 1996;71:1182-1191.
10. Berth-Jones J, Graham-Brown RAC, Marks R et al. Long term efficacy and safety of cyclosporine in severe adult atopic dermatitis. Br J Dermatol 1997;136:76-81.
11. Dutz JP, Ho VC. Immunosuppressive agents in dermatology. An update. Dermatol Clin 1998;16:235-251.
12. Naeyaert JM, Lachapelle JM, Degreef H et al. Cyclosporin in atopic dermatitis: Review of the literature and outline of a Belgian consensus. Dermatology 1999;198:145-152.
13. Fontaine J, Olivry T. Treatment of canine atopic dermatitis with cyclosporine: a pilot clinical study. Vet Rec 2001;148:662-663.
14. Mueller RS, Bettenay SV. Long term immunotherapy of 146 dogs with atopic dermatitis - a retrospective study. Aust Vet Pract 1996;26:128-132.
15. Gather JC, Abramovits W, Menter A. Cyclosporin and tacrolimus in dermatology. Dermatol Clin 2001;19:119-137.
16. Ryffel B. Experimental toxicological studies with Cyclosporin A. In: Cyclosporin A. White DJG, editor. Elsiever Biochemical Press, Amsterdam, 1982:45-75.
17. De Boer DJ, Marsella R. The ACVD task force on canine atopic dermatitis (XII): The relationship of cutaneous infections to the pathogenesis and clinical course of canine atopic dermatitis. Vet Immunol Immunopathol 2001;81:239-249.